Cargando…
Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms’ Tumor: A CIBMTR retrospective analysis
Despite the dramatic improvement in the overall survival for patients diagnosed with Wilms’ tumor (WT), the outcomes for those that experience relapse have remained disappointing. We describe the outcomes of 253 patients with relapsed WT who received high-dose chemotherapy (HDT) followed by autologo...
Autores principales: | Malogolowkin, Marcio H., Hemmer, Michael T., Le-Rademacher, Jennifer, Hale, Gregory A, Metha, Parinda A., Smith, Angela R., Kitko, Carrie, Abraham, Allistair, Abdel-Azim, Hisham, Dandoy, Christopher, Diaz, Miguel Angel, Gale, Robert Peter, Guilcher, Greg, Hayashi, Robert, Jodele, Sonata, Kasow, Kimberly A., MacMillian, Margaret L., Thakar, Monica, Wirk, Baldeep M., Woolfrey, Ann, Thiel, E L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665725/ https://www.ncbi.nlm.nih.gov/pubmed/28869618 http://dx.doi.org/10.1038/bmt.2017.178 |
Ejemplares similares
-
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR NEUROBLASTOMA: THE CIBMTR EXPERIENCE
por: Hale, Gregory A., et al.
Publicado: (2013) -
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR(®) analysis
por: Williams, Kirsten M., et al.
Publicado: (2016) -
NMDP/CIBMTR donor selection guidelines
Publicado: (2019) -
COVID-19 in Pediatric Hematopoietic Cell Transplant Recipients: A CIBMTR Study
por: Bhatt, Neel S., et al.
Publicado: (2021) -
COVID-19 in Hematopoietic Cell Transplant Recipients: A CIBMTR Study
por: Sharma, Akshay, et al.
Publicado: (2021)